Prospective study evaluating aflibercept in patients with recurrent or prolonged diabetic macular edema after vitrectomy
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2016
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 30 Jun 2016 Planned End Date changed from 1 Feb 2017 to 31 Mar 2019.
- 13 Feb 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.
- 06 Jan 2015 New trial record